Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection

Tugba Ozturk, J Christina Howell, View ORCID ProfileKarima Benameur, Richard Ramonell, Kevin S. Cashman, Shama Pirmohammed, Leda C. Bassit, John D. Roback, Vincent C. Marconi, Raymond F. Schinazi, Whitney Wharton, F. Eun-Hyung Lee, View ORCID ProfileWilliam T Hu
doi: https://doi.org/10.1101/2020.05.10.20097535
Tugba Ozturk
1Departments of Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Christina Howell
1Departments of Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karima Benameur
1Departments of Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karima Benameur
Richard Ramonell
2Medicine – Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin S. Cashman
3Medicine-Rheumatology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shama Pirmohammed
1Departments of Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leda C. Bassit
4Pediatrics and Center for AIDS Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Roback
5Laboratory Medicine and Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent C. Marconi
6Medicine – Division of Infectious Diseases, Emory University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond F. Schinazi
4Pediatrics and Center for AIDS Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Whitney Wharton
7Emory University Nell Hodgson Woodruff School of Nursing, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Eun-Hyung Lee
2Medicine – Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William T Hu
1Departments of Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William T Hu
  • For correspondence: william.hu@emory.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Accurate serological assays can improve the early diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but few studies have compared performance characteristics between assays in symptomatic and recovered patients.

Methods We recruited 32 patients who had 2019 coronavirus disease (COVID-19; 18 hospitalized and actively symptomatic, 14 recovered mild cases), and measured levels of IgM (against the full-length S1 or the highly homologous SARS-CoV E protein) and IgG (against S1 receptor binding domain [RBD]). We performed the same analysis in 103 pre-2020 healthy adult control (HC) participants and 13 participants who had negative molecular testing for SARS-CoV-2.

Results Anti-S1-RBD IgG levels were very elevated within days of symptom onset for hospitalized patients (median 2.04 optical density [OD], vs. 0.12 in HC). People who recovered from milder COVID-19 only reached similar IgG levels 28 days after symptom onset. IgM levels were elevated early in both groups (median 1.91 and 2.12 vs. 1.14 OD in HC for anti-S1 IgM, 2.23 and 2.26 vs 1.52 in HC for anti-E IgM), with downward trends in hospitalized cases having longer disease duration. The combination of the two IgM levels showed similar sensitivity for COVID-19 as IgG but greater specificity, and identified 4/10 people (vs. 3/10 by IgG) with prior symptoms and negative molecular testing to have had COVID-19.

Conclusions Disease severity and timing both influence levels of IgM and IgG against SARS-CoV-2, with IgG better for early detection of severe cases but IgM more suited for early detection of milder cases.

Competing Interest Statement

Dr. Hu and Emory University have licensed the IgM assay panel for SARS-CoV-2, have a patent on the CSF-based diagnosis of FTLD-TDP, and have a patent pending on the CSF-based prognosis of spinal muscular atrophy; Dr. Hu has consulted for ViveBio, LLC, AARP, Inc, and Biogen, Inc.; and has received research support from Fujirebio US. Dr. Lee is the founder of MicroB-plex, Inc and has research grants with Genentech.

Funding Statement

This work was supported by National Institutes of Health grants R01 AG 054046, R01 AG054991, and T32HL116271.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available upon reasonable request one year following publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 14, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection
Tugba Ozturk, J Christina Howell, Karima Benameur, Richard Ramonell, Kevin S. Cashman, Shama Pirmohammed, Leda C. Bassit, John D. Roback, Vincent C. Marconi, Raymond F. Schinazi, Whitney Wharton, F. Eun-Hyung Lee, William T Hu
medRxiv 2020.05.10.20097535; doi: https://doi.org/10.1101/2020.05.10.20097535
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection
Tugba Ozturk, J Christina Howell, Karima Benameur, Richard Ramonell, Kevin S. Cashman, Shama Pirmohammed, Leda C. Bassit, John D. Roback, Vincent C. Marconi, Raymond F. Schinazi, Whitney Wharton, F. Eun-Hyung Lee, William T Hu
medRxiv 2020.05.10.20097535; doi: https://doi.org/10.1101/2020.05.10.20097535

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1437)
  • Dentistry and Oral Medicine (221)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (590)
  • Epidemiology (10339)
  • Forensic Medicine (6)
  • Gastroenterology (534)
  • Genetic and Genomic Medicine (2658)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1746)
  • Health Policy (791)
  • Health Systems and Quality Improvement (683)
  • Hematology (270)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12123)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2486)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (498)
  • Occupational and Environmental Health (569)
  • Oncology (1338)
  • Ophthalmology (404)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (787)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2424)
  • Public and Global Health (5035)
  • Radiology and Imaging (903)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (258)
  • Sports Medicine (246)
  • Surgery (301)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)